Design Therapeutics, Inc. DSGN Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$17.64M-10.2% | -$16M+5.9% | -$17M+10.9% | -$19.08M-7.7% | -$17.72M-29.8% | ||
| $157K+0.6% | $156K+0.6% | $155K+2.0% | $152K-4.4% | $159K+6.7% | ||
| $3.92M+14.2% | $3.44M-4.3% | $3.59M-9.9% | $3.99M+12.6% | $3.54M+2.0% | ||
| -$2.51M-236% | $1.84M-23.5% | $2.41M+344% | $542K+280% | -$301K— | ||
| $287K-67.4% | $880K— | —— | —— | $1.41M+333% | ||
| -$16.43M-37.3% | -$11.97M-7.2% | -$11.16M+22.7% | -$14.44M+14.0% | -$16.79M-70.3% | ||
| $0-100% | $34K— | $0-100% | $87K+20.8% | $72K— | ||
| $52.59M-40.0% | $87.62M+12.2% | $78.08M+97.5% | $39.53M-54.3% | $86.55M+34.4% | ||
| $45M-40.8% | $76.08M-10.1% | $84.59M+41.6% | $59.74M-36.8% | $94.49M+42.7% | ||
| -$7.59M— | —— | $6.51M-67.6% | $20.12M+156% | $7.87M+330% | ||
| $19.91M-19.7% | $24.79M+66,892% | $37K+60.9% | $23K— | $0+100% | ||
| $19.93M-21.3% | $25.32M+68,324% | $37K-89.8% | $361K+1,470% | $23K-91.3% | ||
| -$4.09M— | —— | -$4.62M— | —— | -$8.9M— | ||
| $147K-71.3% | $512K-33.2% | $767K-16.1% | $914K-13.8% | $1.06M-26.3% | ||
| $157K+0.6% | $156K+0.6% | $155K+2.0% | $152K-4.4% | $159K+6.7% | ||
| -$2.51M-236% | $1.84M-23.5% | $2.41M+344% | $542K+280% | -$301K— | ||
| $287K-67.4% | $880K— | —— | —— | $1.41M+333% | ||
| $69K+963% | -$8K-14.3% | -$7K-250% | -$2K+50.0% | -$4K— | ||
| $45M-40.8% | $76.08M-10.1% | $84.59M+41.6% | $59.74M-36.8% | $94.49M+42.7% | ||
| $0— | —— | —— | —— | $54K— | ||
| —— | $4.25K0.0% | $4.25K0.0% | $4.25K0.0% | $4.25K— | ||
| -$16.43M-36.9% | -$12M-7.5% | -$11.16M+23.2% | -$14.53M+13.8% | -$16.86M-71.0% | ||
| -$16.43M-36.9% | -$12M-7.5% | -$11.16M+23.2% | -$14.53M+13.8% | -$16.86M-71.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Design Therapeutics, Inc. generate?
- Design Therapeutics, Inc. (DSGN) generated -$54.0M in operating cash flow over the trailing twelve months.
- What is Design Therapeutics, Inc.'s free cash flow?
- After $121.0K of capital expenditures, Design Therapeutics, Inc.'s free cash flow was -$54.1M over the trailing twelve months, down 13.5% year over year.
- Where does Design Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Design Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.